[0R2M] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[0R2M] Regeneron Pharmaceuticals, Inc.
Announcement Date
09-Feb-2017
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- 40.79%
Quarter Report
0R2M's Result
0R2M's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 6,557,600 6,710,800 5,872,227 4,860,427 4,103,728 2,819,557 2,104,745 20.84%
PBT 2,429,100 2,553,500 2,078,511 1,329,815 1,225,097 775,747 713,360 22.64%
Tax 313,300 109,100 880,000 434,293 589,041 427,673 288,998 1.35%
NP 2,115,800 2,444,400 1,198,511 895,522 636,056 348,074 424,362 30.68%
Tax Rate -12.90% -4.27% -42.34% -32.66% -48.08% -55.13% -40.51% -
Total Cost 4,441,800 4,266,400 4,673,716 3,964,905 3,467,672 2,471,483 1,680,383 17.57%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin 32.26 36.42 20.41 18.42 15.50 12.34 20.16 8.14%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS 19.38 21.29 11.27 8.55 6.17 3.36 4.23 28.86%
EPS Diluted 18.46 21.29 10.34 7.70 5.52 2.98 3.72 30.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.